Home/Filings/4/0001628280-22-000343
4//SEC Filing

Schmidt Joan 4

Accession 0001628280-22-000343

CIK 0001080709other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 5:02 PM ET

Size

5.1 KB

Accession

0001628280-22-000343

Insider Transaction Report

Form 4
Period: 2022-01-03
Schmidt Joan
EVP, General Counsel & Sec
Transactions
  • Award

    Common Stock

    2022-01-03+21,46236,063 total
Footnotes (1)
  • [F1]The amount represents restricted stock units that vest over four years, with 25% of the shares underlying the restricted stock units vesting on February 15, 2023, and the remainder vesting quarterly over the following three years in equal installments (except as otherwise necessary to avoid vesting of a fractional share), with such quarterly vesting dates occurring on the 15th of May, August, November, and February. The shares underlying the restricted stock units will be issued upon vesting and release of the restricted stock units.

Issuer

ARENA PHARMACEUTICALS INC

CIK 0001080709

Entity typeother

Related Parties

1
  • filerCIK 0001805334

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 5:02 PM ET
Size
5.1 KB